The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction
Clinical trial NCT06350487 · UNKNOWN
Trial details
- NCT number
- NCT06350487
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-12-31
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.